No hay resultados disponibles
Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis
Permalink: https://cordis.europa.eu/project/id/813200/results/es
© European Union, 2022